AMR Action Fund Announces Investment in BioVersys AG
This is the last scientific paper about their drug BV 100:
Rifabutin for infusion (BV100) for the treatment of severe carbapenem-resistant Acinetobacter baumannii infections - ScienceDirect
PBT2 is much more valuable than this BV 100 and has much more scientific info published than BV100.
- Forums
- ASX - By Stock
- ATH
- The Fund invested in BioVersys AG
The Fund invested in BioVersys AG
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.5¢ |
Change
0.001(12.5%) |
Mkt cap ! $21.28M |
Open | High | Low | Value | Volume |
0.4¢ | 0.5¢ | 0.4¢ | $508 | 124.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
103 | 97947018 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 24179262 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
103 | 97947018 | 0.004 |
64 | 62451432 | 0.003 |
19 | 34166014 | 0.002 |
16 | 108320102 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 24179262 | 14 |
0.006 | 21637365 | 19 |
0.007 | 28724705 | 25 |
0.008 | 28175438 | 30 |
0.009 | 17668789 | 11 |
Last trade - 11.42am 25/07/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |